TEVA 5.125% 09May2029 Corp (USD)

Bond Factsheet

Teva Pharmaceutical Finance Netherlands III B.V.

Indicative

Full Lot

Bid Price

98.855

Change in Bid Price

0.166

Bid Yield (%)

5.545 %

Change in Bid Yield

remove 0.061

Ask Price

99.196

Change in Ask Price

0.173

Ask Yield (%)

5.419 %

Change in Ask Yield

remove 0.064

Indicative price as of 02 Oct 2026, 4:33pm

chevron_leftchevron_right

Bond Information

Teva Pharmaceutical Finance Netherlands III B.V. operates as a special purpose entity. The Company was formed for the purpose of issuing debt securities to repay existing credit facilities, refinance indebtedness, and for acquisition purposes.

Bond Issuer

Teva Pharmaceutical Finance Netherlands III B.V.

Guarantor

Teva Pharmaceutical Industries Ltd

Announcement Date

02 Nov 2021

Issue Date

09 Nov 2021

Maturity Date

09 May 2029

Years to Maturity / Next Call

2.596 / 2.352

Modified Duration

2.346 @ 02 Oct 2026

Issue / Reoffer Price

100.000

Issue / Reoffer Yield

5.125

Coupon Type

Fixed

Annual Coupon Rate

5.125

Coupon Frequency

Semi Annually

Seniority

Senior Unsecured

Reference Rate

ISIN

US88167AAQ40

CUSIP

88167AAQ4

Bond Currency

USD

Total Issue Size

1,000,000,000

Min. Investment Quantity (Nominal)

USD 200,000

Incremental Quantity (Nominal)

USD 1,000

Bond Type

Corporate

Bond Sector

Health Care

Bond Sub Sector

Pharmaceuticals

Issuer Credit Rating (S&P/ Fitch)

***/ N.R

Bond Credit Rating (S&P/ Fitch)

***/ BBB-

Shariah Compliant

Exchange Listed

Others

Bond Feature(s)

Issuer Call

The issuer redeems the USD notes of any series on or after the applicable Par Call Date for such series, the redemption price for such USD notes will be equal to 100% of the aggregate principal amount of such USD notes being redeemed, plus accrued and unpaid interest thereon, if any, to, but not including, the redemption date.

“Par Call Date” means (i) with respect to the 2027 USD notes February 9, 2027 (the date that is three months prior to the maturity date of the 2027 USD notes) and (ii) with respect to the 2029 USD notes February 9, 2029 (the date that is three months prior to the maturity date of the 2029USD notes).

Coupon Step

Interest Rate Adjustment For 2029 USD notes Upon Failure to Achieve Sustainability Performance Targets

From and including May 9, 2026 (the Step-up Date”), the interest rate payable on the 2029 USD notes (but not the 2027 USD notes) shall increase by:

(a) 0.125% per annum unless Teva has achieved the Regulatory Submissions Target as of the Testing Date;
(b) 0.125% per annum unless Teva has achieved the Product Volume Target as of the Testing Date; and
(c) 0.125% per annum unless Teva has achieved the Emission Reduction Target as of the Testing Date;

in each case, as certified by the Issuer or Teva to the trustee in an officer’s certificate (which shall include the Assurance Letter as an exhibit thereto) on or prior to the Certification Date (subject to any clerical or administrative errors (including any delays resulting therefrom)); provided that, for the avoidance of doubt:

(i) the interest rate on the 2029 USD notes shall not increase on the Step-up Date if Teva has achieved the three Sustainability Performance Targets as of the Testing Date and certified to such on or prior to the Certification Date;

(ii) the increase in the interest rate on the 2029 USD notes on the Step-up Date shall not exceed a total of 0.125% if Teva has achieved two of the three Sustainability Performance Targets as of the Testing Date and certified to such on or prior to the Certification Date;

(iii) the increase in the interest rate on the 2029 USD notes on the Step-up Date shall not exceed a total of 0.250% if Teva has met one of the three Sustainability Performance Targets as of the Testing Date and certified to such on or prior to the Certification Date; and

(iv) in no event shall the total increase in the interest rate on the 2029 USD notes on the Step-up Date exceed 0.375% (this being the consequence of Teva failing to achieve any of the three Sustainability Performance Targets on the Testing Date and failing to certify to achievement on or prior to the Certification Date).

Make Whole Call

The issuer may redeem the USD notes of any series, in whole or in part, at any time or from time to time, on at least 10days’, but not more than 60 days’, prior notice delivered to the registered address of each holder of the USD notes to be redeemed, with a copy of such notice delivered to the trustee. The redemption prices will be equal to the greater of (1) 100% of the principal amount of the USD notes to be redeemed or (2) the sum of the present values of the Remaining Scheduled Payments (as defined below) on the USD notes being redeemed discounted, on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months), using a discount rate equal to the sum of the Treasury Rate (as defined below) plus 50 basis points, in the case of the 2027 USD notes, and 50 basis points, in the case of the 2029 USD notes, plus in each case accrued and unpaid interest thereon, if any, to, but not including, the redemption date;

“Par Call Date” means (i) with respect to the 2027 USD notes February 9, 2027 (the date that is three months prior to the maturity date of the 2027 USD notes) and (ii) with respect to the 2029 USD notes February 9, 2029 (the date that is three months prior to the maturity date of the 2029USD notes).

Bondsupermart strives to ensure the accuracy and relevance of the information provided here. If the information is not up-to-date or erroneous, we appreciate feedback to keep it accurate.

Coupon Dates	Coupon Receive	Principal Amount	Cash Flow

No Data